REPUBLIC OF BULGARIA
NATIONAL COUNCIL ON PRICES AND REIMBURSEMENT OF MEDICINAL PRODUCTS
For citizens
For business
Home
NCPRMP
About Council
Composition
Structure
Code of ethics
Annual reports
Regulations
European Legislation
Bulgarian Legislation
Legislation
Regulations
Tariffs
Administrative Services
Еlectronic administrative services
Business hours of the Administrative Service Unit
Bank account
Procedure for provision of administrative services
Document templates
Notifications under Art. 61 para. 3 of APC
Access to public information
Registers
Electronic registers
Annex № 1 to PDL
Annex № 2 to PDL
Annex № 3 to PDL
Annex № 4 to PDL
Ceiling prices register
Maximum sales prices register
Archive of registers
Archive of registers for 2013
Archive of registers for 2014 г.
Archive of registers for 2015 г.
Prices and Reimbursement
Reference states
Instructions
Schedule for official check under Art 43, para. 3
Health Technology Assessment
Regulations
Summary of HTA reports
Positive decision for inclusion in PDL
Negative decision for inclusion in PDL
Monitoring the effect of therapy
Pharmacotherapeutic guidances
РЕПУБЛИКА БЪЛГАРИЯ
НАЦИОНАЛЕН СЪВЕТ ПО ЦЕНИ И РЕИМБУСИРАНЕ НА ЛЕКАРСТВЕНИ ПРОДУКТИ
For citizens
For business
Home
NCPRMP
About Council
Composition
Structure
Code of ethics
Annual reports
Regulations
European Legislation
Bulgarian Legislation
Legislation
Regulations
Tariffs
Administrative Services
Еlectronic administrative services
Business hours of the Administrative Service Unit
Bank account
Procedure for provision of administrative services
Document templates
Notifications under Art. 61 para. 3 of APC
Access to public information
Registers
Electronic registers
Annex № 1 to PDL
Annex № 2 to PDL
Annex № 3 to PDL
Annex № 4 to PDL
Ceiling prices register
Maximum sales prices register
Archive of registers
Archive of registers for 2013
Archive of registers for 2014 г.
Archive of registers for 2015 г.
Prices and Reimbursement
Reference states
Instructions
Schedule for official check under Art 43, para. 3
Health Technology Assessment
Regulations
Summary of HTA reports
Positive decision for inclusion in PDL
Negative decision for inclusion in PDL
Monitoring the effect of therapy
Pharmacotherapeutic guidances
You can download and view the application in .XlS format
HERE.
